TITLE

Quality of Health Care in Inflammatory Bowel Disease: Development of a Reliable Questionnaire (QUOTE-IBD) and First Results

AUTHOR(S)
Van der Eijk, Ingrid; Sixma, Herman; Smeets, Tamara; Veloso, Fernando Tavarela; Odes, Selwyn; Montague, Sean; Fomaciari, Giovanni; Moum, Björn; Stockbrügger, Reinhold; Russel, Maurice
PUB. DATE
December 2001
SOURCE
American Journal of Gastroenterology;Dec2001, Vol. 96 Issue 12, p3329
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVES: As inflammatory bowel disease is a chronic disorder, usually with an early onset in life, quality of care plays an important role for patients. The aim of this study was to develop a questionnaire to measure quality of care through the eyes of patients with inflammatory bowel disease. METHODS: Ten generic questions were already available because the questionnaire is based on an existing instrument. Patients with inflammatory bowel disease in seven countries were involved in the development of additional disease-specific items. Validation and first field testing of the total questionnaire (QUOTE-IBD) was performed in The Netherlands. RESULTS: A total of 380 patients cooperated in the development of 13 disease-specific items, with high internal reliability (Cronbach's a = 0.83). Another 162 patients were involved in validating and testing of the QUOTE-IBD, which consists of 23 items in total. Pearson's correlation coefficient between QUOTE-IBD and visual analog scale scores of health care items was 0.55. Intraclass correlation coefficient of two assessments was 0.64. First testing showed that patients gave relatively poor marks to some part of health care services, such as providing information about extraintestinal complaints and the psychological as well as physical approach to complaints. CONCLUSIONS: A short, valid, reliable questionnaire was developed to measure the opinions of patients with inflammatory bowel disease on quality of health care. The QUOTE-IBD can be used for identification of areas for improvement, with the aim of optimizing health care in inflammatory bowel disease.
ACCESSION #
17611853

 

Related Articles

  • Use of Pharmaceuticals by Inflammatory Bowel Disease Patients: A Population-Based Study. Metge, Colleen J.; Blanchard, James F.; Peterson, Sandra; Bernstein, Charles N. // American Journal of Gastroenterology;Dec2001, Vol. 96 Issue 12, p3348 

    OBJECTIVES: In 1996 we created the population-based University of Manitoba Inflammatory Bowel Disease {IBD) Database. In 1994, Manitoba Health established the Drug Program Information Network (DPIN). which identified all ambulatory prescription drugs dispensed to each individual resident of the...

  • Cross-Cultural Variation in Disease-Related Concerns Among Patients With Inflammatory Bowel Disease. Levenstein, Susan; Zhiming Li; Almer, Sven; Barbosa, Antonio; Marquis, Patrick; Moser, Gabriele; Sperber, Ami; Toner, Brenda; Drossman, Douglas A. // American Journal of Gastroenterology;Jun2001, Vol. 96 Issue 6, p1822 

    OBJECTIVE: The aim of this work was to study cross-cultural variations in the impact of inflammatory bowel disease (IBD) on health-related quality of life by an international comparison of disease-related concerns. METHODS: Item and factor scores on the Rating Form of Inflammatory Bowel Disease...

  • Analyzing Hospital Costs for Patients With Inflammatory Bowel Disease. Picco, Michael F.; Bayless, Theodore M. // American Journal of Gastroenterology;Mar2000, Vol. 95 Issue 3, p577 

    Analyzes hospital costs for patients with inflammatory bowel disease. Lack of consideration on the heterogeneity of the disease; Limitation of data presented in the analysis; Approach to understand the natural history of the disease.

  • A PATIENT CENTRED APPROACH TO MEASURING THE IMPACT OF FAECAL INCONTINENCE IN IRD.  // Gut;Apr2004 Supplement 3, Vol. 53, pA102 

    This article reports on the development and preliminary validation of a new scale to measure the impact of faecal incontinence (Fl) in patients with inflammatory bowel disease (IBD). Fl has been defined as the involuntary or inappropriate passage of kieces. Here researchers have used a broader...

  • Acute distal colitis impairs gastric emptying in rats via an extrinsic neuronal reflex pathway involving the pelvic nerve. De Schepper, H. U.; De Man, I. G.; Van Nassauw, I.; Timmermans, J.-P.; Herman, A. G.; Pelckmans, P. A.; De Winter, B. Y. // Gut;Feb2007, Vol. 56 Issue 2, p195 

    Background and aims: Patients with inflammatory bowel disease often present with abnormal gut motility away from the inflammatory site. We studied remote motility disturbances and their pathophysiology in a rat model of colitis. Methods: Colitis was induced 72 h prior to experiments using...

  • Altered Bone Metabolism in Inflammatory Bowel Disease. Bischoff, Stephan C.; Herrmann, Annette; Göke, Michael; Manns, Michael P.; Von zur Mühlen, Alexander; Brabant, Georg // American Journal of Gastroenterology;Jul1997, Vol. 92 Issue 7, p1157 

    A reduced bone mineral density has been reported in inflammatory bowel disease (IBD). Objective: To assess the mechanisms of bone disease in IBD. Methods: We studied in 90 patients (61 with Crohn's disease, 22 with ulcerative colitis, 7 with indeterminate colitis) biochemical markers of bone...

  • Malpractice Risks Associated with Colon Cancer and Inflammatory Bowel Disease. Feld, Andrew D. // American Journal of Gastroenterology;Sep2004, Vol. 99 Issue 9, p1641 

    Analyses of lawsuits against gastroenterologists suggest that the disorders of colon cancer and inflammatory bowel disease are among the more common disorders resulting in malpractice claims, with colon cancer suits receiving some of the highest monetary judgments. Unfortunately, that composite...

  • Heightened Responses to Stressors in Patients with Inflammatory Bowel Disease. Farhadi, Ashkan; Keshavarzian, Ali; van de Kar, Louis D.; Jakate, Shriram; Domm, Aaron; Lei Zhang; Shaikh, Maliha; Banan, Ali; Fields, Jeremy Z. // American Journal of Gastroenterology;Aug2005, Vol. 100 Issue 8, p1796 

    OBJECTIVES: Several studies suggest that stressful situations (stressors) worsen the course of inflammatory bowel disease (IBD), but the mechanism is not known. Based on several lines of evidence, we hypothesized that psychosocial stress activates the brain-gut axis (BGA) and mucosal mast cells...

  • PROSPECTIVE STUDY OF THIOGUANINE NUCLEOTIDE MEASUREMENT DURING AZATHIOPRIPIE TREATMENT FOR INFLAMMATORY BOWEL DISEASE.  // Gut;Apr2004 Supplement 3, Vol. 53, pA105 

    6-thioguanine nucleotides (IGN) are considered to be the active cytotoxic metabolite of azathioprine (ALA) although the exact mechanism action of the drug is by no means understood. Patients entering the study were treated with AZA at 2 mg/ kg for at least 6 months. Blood for TGN level was taken...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics